Ratos announces offer document
This information is disclosed in accordance with the Securities Markets Act and NASDAQ OMX Stockholm's rules regarding public offers on the stock market.
This press release may not be distributed, directly or indirectly, in or into, Australia, Canada, Japan, New Zealand, South Africa, Switzerland or the United States of America. The Offer is not being made to (and acceptances will not be accepted from) persons in those countries or in any other country where the making of the Offer, the distribution of this press release or acceptance of the Offer requires further offer documents, filings or other measures in addition to those required by Swedish law. Ratos has today announced the offer document regarding the offer to the shareholders and convertible debenture holders of Biolin Scientific to tender all their outstanding shares and convertible debentures in Biolin Scientific to Ratos. The offer document is available in a Swedish language version only. The offer document will be mailed to all directly registered shareholders and convertible debenture holders of Biolin Scientific and can be ordered from ABG Sundal Collier, +46 8 566 286 00. The offer document will also be available at Ratos's office, Drottninggatan 2, 111 96 Stockholm, Sweden, at ABG Sundal Collier's office, Regeringsgatan 65, 5tr, 103 89 Stockholm, Sweden, as well as at Remium's office, Kungsgatan 12-14, 111 35 Stockholm, Sweden. The offer document is also available on www.ratos.se, www.abgsc.se and www.remium.se. The acceptance period for the offer is expected to commence on 1 December 2010 and end on 21 December 2010. Stockholm, 30 November 2010 Ratos AB The Board of Directors For further information, please contact: Arne Karlsson, CEO, +46 8 700 17 00 Emma Rheborg, Head of Corporate Communications & IR, +46 8 700 17 20 Financial calendar from Ratos: Year-end report 2010 17 February 2011 Annual General Meeting 2011 5 April 2011 Interim Report January - March 2011 5 May 2011 Interim Report January - June 2011 19 August 2011 Interim Report January - September 2011 9 November 2011 Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos offers investors a unique investment opportunity. Ratos's equity is approximately SEK 14 billion and has a market capitalisation of approximately SEK 36 billion. Ratos's holdings include AH Industries, Anticimex, Arcus Gruppen, Bisnode, Camfil, Contex, DIAB, EuroMaint, GS-Hydro, Hafa Bathroom Group, HL Display, Inwido, Jøtul, Lindab, Medisize, Mobile Climate Control, SB Seating, Stofa, Superfos and Other holdings.